Clinical Trials Logo

Filter by:
NCT ID: NCT00715416 Completed - Clinical trials for Intermittent Claudication

PTA vs. Primary Stenting of SFA Using Self-Expandable Nitinol Stents

Start date: June 2004
Phase: Phase 4
Study type: Interventional

The investigators evaluated whether primary implantation of a self-expanding nitinol stent yielded anatomical and clinical benefits superior to those afforded by percutaneous transluminal angioplasty with optional secondary stenting.

NCT ID: NCT00714961 Completed - Clinical trials for Acute Coronary Syndromes

Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial Infarction

CLARITY-TIMI28
Start date: February 2003
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if the combination of aspirin plus clopidogrel is more effective than aspirin alone in preventing another heart attack, chest pain, stroke or death in people who have already had a heart attack that was treated with fibrinolytic therapy.

NCT ID: NCT00714493 Completed - Clinical trials for Rheumatoid Arthritis

RESTART C0168Z05 Rheumatoid Arthritis Study

Start date: July 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess the effectiveness of treatment in patients with active rheumatoid arthritis who are having an inadequate response to at least 3 months of treatment with etanercept or adalimumab in addition to methotrexate.

NCT ID: NCT00714415 Completed - Hemophilia B Clinical Trials

Registry For Patients Treated With BeneFix In Usual Care Setting In Germany

Start date: January 2008
Phase:
Study type: Observational

The purpose of this observational study is to describe the incidence of adverse events among patients treated with BeneFix® in usual health care settings in Germany.

NCT ID: NCT00714311 Completed - Clinical trials for Borderline Personality Disorder

Efficacy of Transference-Focused Psychotherapy for Borderline Personality Disorder

Start date: October 2004
Phase: N/A
Study type: Interventional

The purpose of this study is to find out whether Transference-Focused Psychotherapy (TFP) is effective in the treatment of Borderline Personality Disorder.

NCT ID: NCT00713648 Completed - Clinical trials for Congenital Bleeding Disorder

Evaluation of Recombinant Factor XIII for Prevention of Bleeding in Patients With FXIII Inherited Deficiency

Start date: August 2008
Phase: Phase 3
Study type: Interventional

The trial is conducted in Europe, North America and Asia. The aim of this trial is to evaluate catridecacog (recombinant factor XIII (rFXIII)) treatment in patients with inherited FXIII deficiency. It is expected that recombinant FXIII can be used for the prevention of bleeding episodes.

NCT ID: NCT00713622 Completed - Epilepsy Clinical Trials

Comparing The Effect On Cognition Of Adjunctive Therapy With Zonisamide Versus Sodium Valproate

Start date: June 2008
Phase: Phase 4
Study type: Interventional

Zonisamide (Zonegran) and sodium valproate (Epilim) are both medicines approved to treat epilepsy. The purpose of this study is to find out the extent to which zonisamide may affect memory and concentration, compared to sodium valproate.

NCT ID: NCT00713518 Completed - Clinical trials for Age Related Macular Degeneration

Phase II Open Label Multicenter Study For Age Related Macular Degeneration Comparing PF-04523655 Versus Lucentis In The Treatment Of Subjects With CNV (MONET Study).

MONET
Start date: November 2009
Phase: Phase 2
Study type: Interventional

The aim of the study is to evaluate whether PF-04523655 is effective in the treatment of neovascular/wet AMD and at which dose.

NCT ID: NCT00712933 Completed - Clinical trials for Systemic Lupus Erythematosus

A Continuation Trial for Subjects With Lupus That Completed Protocol HGS1006-C1056 or HGS1006-C1057

Start date: May 30, 2008
Phase: Phase 3
Study type: Interventional

This is a long-term continuation study to provide continuing treatment to subjects with SLE.

NCT ID: NCT00712907 Completed - Regional Blood Flow Clinical Trials

Effects of Vitamin C on Hyperoxia-Induced Reduction of Retinal Blood Flow

Start date: February 2003
Phase: N/A
Study type: Interventional

High arterial blood oxygen tension leads to vasoconstriction of retinal vessels, possibly related to an interaction between reactive oxygen species and endothelium-derived vasoactive factors. Vitamin C is a potent antioxidant capable of reversing endothelial dysfunction due to increased oxidant stress. Vitamin C appears to have vasodilatory properties, but the underlying mechanisms are not well understood. In the present study we hypothesized that hyperoxic vasoconstriction of retinal vessels could be diminished by vitamin C. Ocular blood flow will be determined by non-invasive methods, including laser Doppler velocimetry and the Zeiss retinal vessel analyser.